Core Viewpoint - Guoke Photon (Jinan) Laser Technology Co., Ltd. has signed a seed round equity investment agreement, marking a significant step in the high-end medical equipment sector in Shandong, showcasing its innovative capabilities in laser medical equipment [2] Group 1: Investment and Partnerships - Jinan Financial Investment Group, through its Haiyou Talent Fund, is the lead investor in the seed round for Guoke Photon, with Tianjin Hongcheng Yizhen Technology Co., Ltd. participating as a market-driven co-investor [2] - The investment will be utilized for product finalization, pre-clinical research, and patent layout [2] Group 2: Technological Advancements - Guoke Photon has developed the world's first ultra-broadband tunable laser medical device, achieving a principle breakthrough in laser medical equipment, enhancing surgical precision to the single-cell level [2] - The prototype of the ultra-broadband tunable laser ablation treatment device can cover the entire spectrum from short-wave infrared to mid-infrared, with performance parameters reaching international leading standards [2] - This device is applicable for minimally invasive treatments of diseases such as brain and spinal tumors, liver diseases, and prostate hyperplasia, significantly improving surgical precision compared to conventional brain tissue surgery methods [2] Group 3: Future Directions - Jinan City will continue to optimize the technology finance service system, promoting the integration of technology, industry, and finance to support the construction of a high-level technology strong city [3]

Core Insights - Guoke Photon (Jinan) Laser Technology Co., Ltd. has signed a seed round equity investment agreement to accelerate the commercialization of its technology [1] - The company focuses on high-end medical equipment development, with its core technology being ultra-broadband tunable laser technology [1] - Guoke Photon has successfully developed the world's first ultra-broadband tunable laser medical device prototype, which is applicable for precise treatment of brain and spinal tumors, liver diseases, and more [1] Investment Details - The investment round is led by Jinan Financial Group's Haiyou Talent Fund, with Tianjin Hongcheng Yizhen Technology participating [1] - The funds will be used for product finalization, preclinical research, and patent layout [1] Company Background - Guoke Photon was established in May 2024 and is incubated by Qilu Zhongke Optics and Engineering Technology Research Institute [1] - The company represents a significant innovation platform for the transformation of research achievements in Jinan [1] - Its business scope includes research and development of electronic special materials, manufacturing and sales of optoelectronic devices, optical instruments, and third-class medical devices [1] - The company possesses full-chain capabilities from core technology research and development to product manufacturing [1]